An IQ Talk seminar titled “Future Medical Care: Cell and Gene Therapy” was held Thursday in Beijing, bringing together experts to discuss advances and challenges in cell and gene therapy (CGT).

Zhou Qi, academician and vice president of the Chinese Academy of Sciences, and president of the University of the Chinese Academy of Sciences, delivered a keynote report entitled "Frontiers, Challenges and Talent Development in Biotechnology."

Zhou highlighted global trends in science and technology, shifts in research paradigms, and opportunities for China in emerging fields such as artificial intelligence, synthetic biology and brain-computer interfaces. He also provided updates on CGT progress and talent cultivation, emphasizing the need for integrated development across education, science and industry.

Experts noted that CGT drugs represent a new frontier in biopharmaceutical innovation, following small molecule and antibody-based therapies. As major economies worldwide prioritize CGT as a strategic focus, Beijing’s advantages in original innovation and clinical resources position the city as a leader in CGT development.

During the exchange session, participants engaged in in-depth discussions on key aspects of the CGT sector, including cutting-edge technologies and applications, industrial development strategies, and talent cultivation and recruitment.

Representatives from leading CGT companies also showcased their latest research and development achievements on-site, providing valuable insights into the current state and future potential of the sector.

IQ Talk is an international collaboration initiative established by the National Torch Academy of Innovation and Entrepreneurship (ZGC) to support Beijing's development of future industries.